Cargando…

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma

BACKGROUND: Abnormal expression of Stathmin 1(STMN1) plays an important role in the proliferation and migration of gallbladder carcinoma (GBC). The purpose of current study is to investigate the prognostic significance of STMN1 in GBC patients after surgery. METHODS: STMN1 expression was evaluated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bo, Xiaobo, Wang, Jie, Fu, Qiang, Wang, Yueqi, Liu, Houbao, Xu, Jiejie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752463/ https://www.ncbi.nlm.nih.gov/pubmed/29312550 http://dx.doi.org/10.18632/oncotarget.19625

Ejemplares similares

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
por: Bo, Xiaobo, et al.
Publicado: (2018)

Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
por: Wang, Jie, et al.
Publicado: (2019)

High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer
por: Bo, Xiaobo, et al.
Publicado: (2020)

Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo
por: Wang, Jiwen, et al.
Publicado: (2016)

Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis
por: Fan, Kun, et al.
Publicado: (2022)

ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer
por: Nan, Lingxi, et al.
Publicado: (2022)

Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling
por: Wang, Yueqi, et al.
Publicado: (2017)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients
por: Xie, Huyang, et al.
Publicado: (2018)

Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single‐cell RNA sequencing
por: Chen, Peizhan, et al.
Publicado: (2021)

Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma
por: Cai, Yongchao, et al.
Publicado: (2022)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
por: Song, Wu, et al.
Publicado: (2012)

Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis
por: Wang, Jiwen, et al.
Publicado: (2017)

Elevated Platelet Distribution Width Predicts Poor Prognosis in Gallbladder Carcinoma
por: Liu, Fei, et al.
Publicado: (2021)

Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer
por: Lian, Shixian, et al.
Publicado: (2015)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients
por: Nan, Lingxi, et al.
Publicado: (2021)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Stathmin guides personalized therapy in oral squamous cell carcinoma
por: Ju, Wu‐tong, et al.
Publicado: (2020)

Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010‐2016
por: Wang, Jie, et al.
Publicado: (2019)

Comparative Survival Benefits of Surgery and Adjuvant Chemotherapy in Neuroendocrine Carcinoma of the Gallbladder: A Population-Based Study with Insight into Future Personalized Therapeutic Approach
por: Khan, Jaffar, et al.
Publicado: (2023)

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway
por: Shen, Sheng, et al.
Publicado: (2016)

Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
por: Chen, Dexin, et al.
Publicado: (2021)

Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
por: Ma, Hai-long, et al.
Publicado: (2017)

Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer
por: Nie, Lekai, et al.
Publicado: (2022)

Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma
por: Geng, Zhi-Min, et al.
Publicado: (2019)

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
por: Wang, Beihe, et al.
Publicado: (2017)

An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis
por: Zhao, Changlei, et al.
Publicado: (2018)

Preoperative Splenic Density for the Prediction of Survival and Adjuvant Chemotherapy Benefits in Gastric Cancer
por: Zhang, Wei-teng, et al.
Publicado: (2020)

Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma
por: LIU, FEI, et al.
Publicado: (2013)

Stathmin Is Dispensable for Tumor Onset in Mice
por: D’Andrea, Sara, et al.
Publicado: (2012)

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

Stathmin drives virus-induced metastasis
por: Whitehouse, Adrian, et al.
Publicado: (2015)

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
por: Curmi, P A, et al.
Publicado: (2000)

Advanced primary squamous cell carcinoma of gallbladder and potential predictive biomarkers for prognosis
por: Li, Jianping, et al.
Publicado: (2020)

Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration
por: Chen, Yan, et al.
Publicado: (2016)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j8p70jk42qhruqdq6ksht2ovf4